Silverarc Capital Management, LLC Portfolio Holdings
Silverarc Capital Management, LLC
- $411 Million
- Q1 2025
Silverarc Capital Management, LLC has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $411 Million distributed in 69 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $34.7M, Merus N.V. with a value of $34.1M, Nuvalent, Inc. with a value of $31.1M, Akero Therapeutics, Inc. with a value of $29.1M, and Insmed Inc with a value of $24.5M.
Examining the 13F form we can see an decrease of $5.19M in the current position value, from $416M to 411M.
Below you can find more details about Silverarc Capital Management, LLC portfolio as well as his latest detailed transactions.